SS

Shaikh Shagir Shaikh Jaldos

Active Director Designated Partner DIN 11941205
DIN 11941205 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shaikh Shagir Shaikh Jaldos

Shaikh Shagir Shaikh Jaldos is a Designated Partner at Novoryn Biosciences Llp (since 2026).

DIN 11941205
Primary Designation Designated Partner
First Appointment 11 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Sep 20262026Active

Board colleagues of Shaikh Shagir Shaikh Jaldos

NameDINCompanyDesignation
Sameer Shaikh Sagir Shaikh11941206Novoryn Biosciences LlpDesignated Partner
Shazeb Istiyaq Ahmad Sayyed11941208Novoryn Biosciences LlpDesignated Partner
Shoyeb Ahmad Sagir Shaikh11941207Novoryn Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Novoryn Biosciences Llp
Premium access

Shareholding and investment profile for Shaikh Shagir Shaikh Jaldos

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaikh Shagir Shaikh Jaldos

Shaikh Shagir Shaikh Jaldos currently holds 1 directorship: Novoryn Biosciences Llp (Designated Partner, since 11 Sep 2026).

Shaikh Shagir Shaikh Jaldos was first appointed on 11 Sep 2026 as Designated Partner at Novoryn Biosciences Llp.

The current boards of Shaikh Shagir Shaikh Jaldos's companies include Sameer Shaikh Sagir Shaikh (Novoryn Biosciences Llp), Shazeb Istiyaq Ahmad Sayyed (Novoryn Biosciences Llp), Shoyeb Ahmad Sagir Shaikh (Novoryn Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available